Associations of estradiol and testosterone with serum phosphorus in older men: The Osteoporotic Fractures in men study

Kidney International

Volumn 78, Issue 4, 2010, Pages 415-422

  Meng, Jerry ^a,b   Ohlsson, Claes ^c   Laughlin, Gail A ^d   Chonchol, Michel ^e   Wassel, Christina L ^d   Ljunggren, Osten ^f   Karlsson, Magnus K ^g   Mellstrom, Dan ^c   Orwoll, Eric S ^h   Barrett Connor, Elizabeth ^d   Ix, Joachim H ^a,b,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UPPSALA UNIVERSITY   (Sweden)

^g LUND UNIVERSITY   (Sweden)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cardiovascular disease; estradiol; kidney disease; phosphorus; sex hormones; testosterone

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VITAMIN D;

AGED; ARTICLE; BONE DENSITY; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMMUNITY ASSESSMENT; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; ETHNICITY; FRAGILITY FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PHOSPHATURIA; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 77955171788     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.161     Document Type: Article

References (39)

1. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
2. Foley RN, Collins AJ, Ishani A et al. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 556-563.
3. Tonelli M, Sacks F, Pfeffer M et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633.
4. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
5. Foley RN, Collins AJ, Herzog CA et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404.
6. Ix JH, De Boer IH, Peralta CA et al. Serum phosphorus concentrations and arterial stiffness among persons with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 2009; 4: 609-615.
7. Meng J, Wassel CL, Kestenbaum BR et al. Serum phosphorus levels and the spectrum of ankle brachial index in older men: The Osteoporotic Fractures in Men (MrOs) Study. Am J Epidemiol 2010; 171: 909-916.
8. de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2009; 53: 399-407.
9. Cirillo M, Ciacci C, De Santo NG. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 2008; 359: 864-866.
10. Onufrak SJ, Bellasi A, Cardarelli F et al. Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol 2009; 169: 67-77.
11. Faroqui S, Levi M, Soleimani M et al. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int 2008; 73: 1141-1150.
12. Marsell R, Mirza MA, Mallmin H et al. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int 2009; 20: 1167-1173.
13. Forster IC, Hernando N, Biber J et al. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int 2006; 70: 1548-1559.
14. Beck L, Karaplis AC, Amizuka N et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 1998; 95: 5372-5377.
15. Hoag HM, Martel J, Gauthier C et al. Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression. J Clin Invest 1999; 104: 679-686.
16. Adami S, Gatti D, Bertoldo F et al. The effects of menopause and estrogen replacement therapy on the renal handling of calcium. Osteoporos Int 1992; 2: 180-185.
17. Stock JL, Coderre JA, Mallette LE. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab 1985; 61: 595-600.
18. Stock JL, Coderre JA, Posillico JT. Effects of estrogen on mineral metabolism in postmenopausal women as evaluated by multiple assays measuring parathyrin bioactivity. Clin Chem 1989; 35: 18-22.
19. Uemura H, Irahara M, Yoneda N et al. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab 2000; 85: 1215-1219.
20. Davidoff M, Caffier H, Schiebler TH. Steroid hormone binding receptors in the rat kidney. Histochemistry 1980; 69: 39-48.
21. Carrillo-Lopez N, Roman-Garcia P, Rodriguez-Rebollar A et al. Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol 2009; 20: 2009-2017.
22. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18: 1637-1647.
23. Ralston SH, Fogelman I, Leggate J et al. Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy. Maturitas 1984; 6: 341-344.
24. Burnett-Bowie SM, Mendoza N, Leder BZ. Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. Bone 2007; 40: 913-918.
25. Vanderschueren D, Van Herck E, Suiker AM et al. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 1992; 130: 2906-2916.
26. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999; 84: 4677-4694.
27. Jones ME, Boon WC, Proietto J et al. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006; 17: 55-64.
28. Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond) 2007; 31: 457-465.
29. Blank JB, Cawthon PM, Carrion-Petersen ML et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 2005; 26: 557-568.
30. Orwoll E, Blank JB, Barrett-Connor E et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005; 26: 569-585.
31. Sodergard R, Backstrom T, Shanbhag V et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801-810.
32. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
33. Mellstrom D, Vandenput L, Mallmin H et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res 2008; 23: 1552-1560.
34. Marsell R, Grundberg E, Krajisnik T et al. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol 2008; 158: 125-129.
35. Pahor M, Chrischilles EA, Guralnik JM et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-411.
36. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
37. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2001; 11: A0828.
38. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
39. Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002; 87: 4957-4960.